Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Moodys
AstraZeneca
Express Scripts
Dow

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Neos Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Neos Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-12-13
Court District Court, D. Delaware Date Terminated 2019-01-02
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties NEOS THERAPEUTICS, INC.; NEOS THERAPEUTICS, LP; TEVA PHARMACEUTICALS USA, INC.
Patents 8,840,924; 9,072,680; 9,089,496
Attorneys Alison S. Cooney; Eric J. Shinabarger; Jack B. Blumenfeld; James L. Higgins; Jeremy A. Tigan; Kevin E. Warner; Melanie K. Sharp; Michael K. Nutter
Firms Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Neos Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Neos Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 .S. patents by Teva: U.S. Patent Nos. 8,840,924 (“the ‘924 patent”); 9,072,680 (“the ‘680 patent”); and…. 13. The ‘924 patent, the ‘680 patent, and the ‘496 patent are all listed for COTEMPLA… the expiration of the ‘924 patent, the ‘680 patent, and the ‘496 patent. 15. Pursuant to… that the claims of the ‘924 patent, the ‘680 patent, and the ‘496 patent are invalid and/or will not…allegations with respect to the ‘924 patent, the ‘680 patent, and the ‘496 patent on or about October 31, 2017 External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,840,924 B2; 9,072,680 B2; 9,089,496…2017 2 January 2019 1:17-cv-01793 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 41 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,840,924 B2 ;9,072,680 B2 ;9,089,496…2017 2 January 2019 1:17-cv-01793 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Johnson and Johnson
Baxter
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.